Cargando…

Antitumor evaluation of two selected Pakistani plant extracts on human bone and breast cancer cell lines

BACKGROUND: The medicinal plants Vincetoxicum arnottianum (VSM), Berberis orthobotrys (BORM), Onosma hispida (OHRM and OHAM) and Caccinia macranthera (CMM) are used traditionally in Pakistan and around the world for the treatment of various diseases including cancer, dermal infections, uterine tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Engel, Nadja, Ali, Iftikhar, Adamus, Anna, Frank, Marcus, Dad, Akber, Ali, Sajjad, Nebe, Barbara, Atif, Muhammad, Ismail, Muhammad, Langer, Peter, Ahmad, Viqar Uddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960692/
https://www.ncbi.nlm.nih.gov/pubmed/27457235
http://dx.doi.org/10.1186/s12906-016-1215-9
_version_ 1782444569608060928
author Engel, Nadja
Ali, Iftikhar
Adamus, Anna
Frank, Marcus
Dad, Akber
Ali, Sajjad
Nebe, Barbara
Atif, Muhammad
Ismail, Muhammad
Langer, Peter
Ahmad, Viqar Uddin
author_facet Engel, Nadja
Ali, Iftikhar
Adamus, Anna
Frank, Marcus
Dad, Akber
Ali, Sajjad
Nebe, Barbara
Atif, Muhammad
Ismail, Muhammad
Langer, Peter
Ahmad, Viqar Uddin
author_sort Engel, Nadja
collection PubMed
description BACKGROUND: The medicinal plants Vincetoxicum arnottianum (VSM), Berberis orthobotrys (BORM), Onosma hispida (OHRM and OHAM) and Caccinia macranthera (CMM) are used traditionally in Pakistan and around the world for the treatment of various diseases including cancer, dermal infections, uterine tumor, wounds etc. The present study focuses on the investigation of the selected Pakistani plants for their potential as anticancer agents on human bone and breast cancer cell lines in comparison with non-tumorigenic control cells. METHODS: The antitumor evaluation was carried out on human bone (MG-63, Saos-2) and breast cancer cell lines (MCF-7, BT-20) in contrast to non-tumorigenic control cells (POB, MCF-12A) via cell viability measurements, cell cycle analysis, Annexin V/PI staining, microscopy based methods as well as migration/invasion determination, metabolic live cell monitoring and western blotting. RESULTS: After the first initial screening of the plant extracts, two extracts (BORM, VSM) revealed the highest potential with regard to its antitumor activity. Both extracts caused a significant reduction of cell viability in the breast and bone cancer cells in a concentration dependent manner. The effect of VSM is achieved primarily by inducing a G2/M arrest in the cell cycle and the stabilization of the actin stress fibers leading to reduced cell motility. By contrast BORM’s cytotoxic properties were caused through the lysosomal-mediated cell death pathway indicated by an upregulation of Bcl-2 expression. CONCLUSIONS: The antitumor evaluation of certain medicinal plants presented in this study identified the methanolic root extract of Berberis orthobotrys and the methanolic extract of Vincetoxicum arnottianum as promising sources for exhibiting the antitumor activity. Therefore, the indigenous use of the herbal remedies for the treatment of cancer and cancer-related diseases has a scientific basis. Moreover, the present study provides a base for phytochemical investigation of the plant extracts. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-016-1215-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4960692
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49606922016-07-27 Antitumor evaluation of two selected Pakistani plant extracts on human bone and breast cancer cell lines Engel, Nadja Ali, Iftikhar Adamus, Anna Frank, Marcus Dad, Akber Ali, Sajjad Nebe, Barbara Atif, Muhammad Ismail, Muhammad Langer, Peter Ahmad, Viqar Uddin BMC Complement Altern Med Research Article BACKGROUND: The medicinal plants Vincetoxicum arnottianum (VSM), Berberis orthobotrys (BORM), Onosma hispida (OHRM and OHAM) and Caccinia macranthera (CMM) are used traditionally in Pakistan and around the world for the treatment of various diseases including cancer, dermal infections, uterine tumor, wounds etc. The present study focuses on the investigation of the selected Pakistani plants for their potential as anticancer agents on human bone and breast cancer cell lines in comparison with non-tumorigenic control cells. METHODS: The antitumor evaluation was carried out on human bone (MG-63, Saos-2) and breast cancer cell lines (MCF-7, BT-20) in contrast to non-tumorigenic control cells (POB, MCF-12A) via cell viability measurements, cell cycle analysis, Annexin V/PI staining, microscopy based methods as well as migration/invasion determination, metabolic live cell monitoring and western blotting. RESULTS: After the first initial screening of the plant extracts, two extracts (BORM, VSM) revealed the highest potential with regard to its antitumor activity. Both extracts caused a significant reduction of cell viability in the breast and bone cancer cells in a concentration dependent manner. The effect of VSM is achieved primarily by inducing a G2/M arrest in the cell cycle and the stabilization of the actin stress fibers leading to reduced cell motility. By contrast BORM’s cytotoxic properties were caused through the lysosomal-mediated cell death pathway indicated by an upregulation of Bcl-2 expression. CONCLUSIONS: The antitumor evaluation of certain medicinal plants presented in this study identified the methanolic root extract of Berberis orthobotrys and the methanolic extract of Vincetoxicum arnottianum as promising sources for exhibiting the antitumor activity. Therefore, the indigenous use of the herbal remedies for the treatment of cancer and cancer-related diseases has a scientific basis. Moreover, the present study provides a base for phytochemical investigation of the plant extracts. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-016-1215-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-26 /pmc/articles/PMC4960692/ /pubmed/27457235 http://dx.doi.org/10.1186/s12906-016-1215-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Engel, Nadja
Ali, Iftikhar
Adamus, Anna
Frank, Marcus
Dad, Akber
Ali, Sajjad
Nebe, Barbara
Atif, Muhammad
Ismail, Muhammad
Langer, Peter
Ahmad, Viqar Uddin
Antitumor evaluation of two selected Pakistani plant extracts on human bone and breast cancer cell lines
title Antitumor evaluation of two selected Pakistani plant extracts on human bone and breast cancer cell lines
title_full Antitumor evaluation of two selected Pakistani plant extracts on human bone and breast cancer cell lines
title_fullStr Antitumor evaluation of two selected Pakistani plant extracts on human bone and breast cancer cell lines
title_full_unstemmed Antitumor evaluation of two selected Pakistani plant extracts on human bone and breast cancer cell lines
title_short Antitumor evaluation of two selected Pakistani plant extracts on human bone and breast cancer cell lines
title_sort antitumor evaluation of two selected pakistani plant extracts on human bone and breast cancer cell lines
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960692/
https://www.ncbi.nlm.nih.gov/pubmed/27457235
http://dx.doi.org/10.1186/s12906-016-1215-9
work_keys_str_mv AT engelnadja antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines
AT aliiftikhar antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines
AT adamusanna antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines
AT frankmarcus antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines
AT dadakber antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines
AT alisajjad antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines
AT nebebarbara antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines
AT atifmuhammad antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines
AT ismailmuhammad antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines
AT langerpeter antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines
AT ahmadviqaruddin antitumorevaluationoftwoselectedpakistaniplantextractsonhumanboneandbreastcancercelllines